Nosis Bio
4 known investors
Nosis develops a platform for receptor-targeted delivery of RNA therapeutics to specific cell types, addressing a key bottleneck in RNA drug development. The company aims to reduce the cost and timeline of bringing new RNA medicines to market.
AI & Machine LearningBiotechDeep TechMedical Devices
Founders & leadership
SM
Seth MyersinFounder
Investors · 4
Competitors · 4
by search overlapbio12 shared keywordsThe Biotechnology Innovation Organization (BIO) is an advocacy organization representing biotech companies, industry leaders, and state biotech associations across the United States and more than 35 countries. It provides members with policy advocacy, cost-saving programs, educational webinars, and organizes the BIO International Convention and other industry conferences.
Syneos Health9 shared keywordsSyneos Health is a contract research and commercialization services company that supports biopharmaceutical companies in drug development, regulatory affairs, and market launch across therapeutic areas. The firm employs over 26,000 specialists including MDs and PhDs to help clients develop and commercialize pharmaceuticals globally.
Syndeio Biosciences8 shared keywordsSyndeio Biosciences is a synapse-focused biotech developing precision neurotherapeutics for neuropsychiatric, mental health, and cognitive disorders such as depression and Alzheimer's. Its proprietary Boost Platform models synapse pharmacology, and its pipeline includes NMDA receptor positive allosteric modulators (zelquistinel and apimostinel) in Phase 2 clinical trials.
Bioworld8 shared keywordsBioWorld is a suite of daily news and data services covering therapeutics, medical technology, biopharma business transactions, and drug R&D, serving biopharmaceutical and medtech industry professionals. Owned by Clarivate, it publishes products including BioWorld, BioWorld Science, and BioWorld Asia with reporting from writers stationed globally.
Companies competing with Nosis Bio for the same Google search keywords, organic and paid, via search-intersection analysis.
Frequently asked questions
- What does Nosis Bio do?
- Nosis develops a platform for receptor-targeted delivery of RNA therapeutics to specific cell types, addressing a key bottleneck in RNA drug development. The company aims to reduce the cost and timeline of bringing new RNA medicines to market.
- Who founded Nosis Bio?
- Nosis Bio was founded by Seth Myers.
- Who are Nosis Bio's investors?
- Nosis Bio's investors include AlleyCorp, Madrona Venture Group, Alley Robotics Ventures, KdT Ventures.